Success Metrics

Clinical Success Rate
100.0%

Based on 12 completed trials

Completion Rate
100%(12/12)
Active Trials
1(4%)
Results Posted
8%(1 trials)

Phase Distribution

Ph not_applicable
12
50%
Ph phase_1
1
4%
Ph phase_3
2
8%
Ph phase_2
1
4%
Ph phase_4
3
13%

Phase Distribution

1

Early Stage

1

Mid Stage

5

Late Stage

Phase Distribution19 total trials
Phase 1Safety & dosage
1(5.3%)
Phase 2Efficacy & side effects
1(5.3%)
Phase 3Large-scale testing
2(10.5%)
Phase 4Post-market surveillance
3(15.8%)
N/ANon-phased studies
12(63.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

12 of 14 finished

Non-Completion Rate

14.3%

2 ended early

Currently Active

1

trials recruiting

Total Trials

24

all time

Status Distribution
Active(1)
Completed(12)
Terminated(2)
Other(9)

Detailed Status

Completed12
unknown9
Withdrawn2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
24
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (5.3%)
Phase 21 (5.3%)
Phase 32 (10.5%)
Phase 43 (15.8%)
N/A12 (63.2%)

Trials by Status

completed1250%
unknown938%
withdrawn28%
active_not_recruiting14%

Recent Activity

Clinical Trials (24)

Showing 20 of 24 trialsScroll for more
NCT05685134Not Applicable

Epicardial Radiofrequency Catheter Ablation in Patients With Brugada Syndrome

Active Not Recruiting
NCT07130175Not Applicable

Radiofrequency Ablation for Polymorphic Ventricular Tachycardia With Heart Failure (RFCA for PMVT-HF)

Completed
NCT06864429Not Applicable

Impact of Catheter Ablation of Frequent Premature Ventricular Complexes in Treating Subtle Left Cardiomyopathy

Completed
NCT03554330Not Applicable

Combined Use of Radiofrequency-ablation and Balloon-septostomy in the Creation of a Stable Inter-atrial Communication

Unknown
NCT03862989

Facilitating Catheter Guidance to Optimal Site for VT Ablation

Withdrawn
NCT03389074

Evaluation of Optimal Ablation Index for Pulmonary Vein Isolation in Patients With AF Prospective Registry

Unknown
NCT02219841

Impact of Life-Style Modification On Ablation Outcome in Atrial Fibrillation

Unknown
NCT01892774

Impact of the Pulmonary Vein Isolation on Exercise Capacity in Patients With Chronic Atrial Fibrillation

Unknown
NCT03816033Not Applicable

Cryotherapy Versus Radiofrequency Catheter Ablation Research Program

Unknown
NCT02533843Phase 3

Outcome of Different Ablation Strategies In Persistent and Long-Standing Persistent Atrial Fibrillation

Completed
NCT01088126Not Applicable

Linear Ablation Versus Focal Ablation of Complex Fractionated Atrial Electrograms in Persistent Atrial Fibrillation

Withdrawn
NCT02208102

Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation

Completed
NCT01711047Not Applicable

Benefit of CFAE Ablation

Completed
NCT01391091Phase 3

Effect of Catheter Ablation on Clinical Course of Migraine in AF Patients With or Without Previous History of Migraine

Completed
NCT02772354Phase 2

Radiofrequency Ablation of Symptomatic Frequent Ventricular Premature Complexes in Pediatric Population

Unknown
NCT02303639Phase 4

Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Ischemic Ventricular Tachyarrhythmias

Unknown
NCT00272636Not Applicable

Radiofrequency Catheter Ablation for Chronic Atrial Fibrillation

Completed
NCT01032317Phase 1

Study of a New Catheter Using Force Sensing Capabilities for the Treatment of Atrial Fibrillation and Ventricular Tachycardia

Completed
NCT02137798Not Applicable

Reduction of Fluoroscopy Exposure During Atrial Fibrillation Ablation

Completed
NCT00674401Not Applicable

Radiofrequency Ablation of Drivers of Atrial Fibrillation

Completed

Drug Details

Intervention Type
DEVICE
Total Trials
24